Related Experiment Video
Updated: May 13, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Adnexal mass referral patterns in Gynecologic Oncology
Rusha Bajpai1, Tammy Mundale1, Natalia Gontarczyk Uczkowski1
1University of Wisconsin, USA.
Referrals for adnexal masses to Gynecologic Oncology increasingly meet American College of Obstetricians and Gynecologists (ACOG) criteria, with a rise in malignant cases over time. This suggests improved referral accuracy, potentially optimizing resource allocation for high-risk patients.
Area of Science:
- Gynecologic Oncology
- Oncology
- Women's Health
Background:
- Adnexal masses are common gynecologic conditions.
- Referral patterns to Gynecologic Oncology for adnexal masses are not well-documented.
- There is a perception of increased referrals not meeting established criteria.
Purpose of the Study:
- To determine the proportion of adnexal mass referrals meeting American College of Obstetricians and Gynecologists (ACOG) criteria over an eleven-year period.
- To analyze trends in referral criteria adherence and malignancy rates.
Main Methods:
- Retrospective chart review of adnexal mass referrals from 2011 to 2021.
- Evaluation of variables including age, menopausal status, imaging, tumor markers, surgery, and histopathology.
- Assessment of adherence to ACOG referral criteria.
Main Results:
- 84.7% of 864 new consults met ACOG referral criteria.
- A significantly higher proportion of consults met criteria in 2021 compared to 2011 (p=0.003).
- The proportion of malignant cases among surgical referrals meeting criteria increased from 37.8% in 2011 to 45.2% in 2021.
Conclusions:
- The proportion of adnexal mass referrals meeting ACOG criteria has increased.
- There is a trending increase in malignant histopathology among these referrals.
- Improved referral scrutiny may decrease benign cases, preserving resources for high-risk patients.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
10:21A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
Published on: March 3, 2023